David H. Jang, MD, MSc FACMT

faculty photo
Assistant Professor of Emergency Medicine
Department: Emergency Medicine

Contact information
Department of Emergency Medicine Research Offices
Blockley Hall
423 Guardian Drive, Room 415

Lab:
The Resuscitation Science Center (RSC)
Leonard and Madlyn Abramson Pediatric Research Center
Lab 814
3615 Civic Center Blvd
Philadelphia, PA 19104
Philadelphia, PA 19104
Fax: 215-898-0868
Education:
BS (Magna cum laude with Department Honors, Psychology and Neuroscience)
University of Massachusetts-Amherst, 2001.
MD (Doctor of Medicine)
Tufts University School of Medicine, 2006.
MSc (Clinical Investigation)
New York University CTSI, 2013.
Post-Graduate Training
Emergency Medicine, University of Pittsburgh, Medical Center Pittsburgh, PA, 2006-2009.
Medical Toxicology, New York University School of Medicine, 2009-2011.
National Heart, Lung and Blood Institute and Emergency Medicine Career Development Program (K12), University of Pennsylvania, 2014-2016.
Certifications
United States Medical Licensing Exam Steps-I-II-III (PASS), 2003.
Advanced Trauma Support (Provider), 2006.
Advanced Cardiac Support (Provider), 2006.
Pediatric Advanced Life Support (Provider), 2006.
Medical Command Physician Pennsylvania Department of Health (Certification), 2007.
Advanced Cardiac Life Support (Instructor), 2008.
American Board of Emergency Medicine-Medical Toxicology Subspecialty , 2012.
American Board of Emergency Medicine, 2012.
Permanent link
 
> Perelman School of Medicine   > Faculty   > Details

Description of Clinical Expertise

Emergency Medicine Residency
University of Pittsburgh
2009

Medical Toxicology Fellowship
New York University School of Medicine
2011

Description of Other Expertise

Attending physician in the Division of Medical Toxicology

Description of Research Expertise

"Abnormal Mitochondrial Function in Acute Care Illness in a Translational Approach from Bench to Bedside."

We are interested in studying the interaction of mitochondrial function in the area of acute care that includes sepsis and acute poisoning. We are currently taking a translational approach studying the mitochondria at a cell-based level, to various animal models, all the way to the clinical setting actively enrolling patients with these acute medical conditions with the goal to develop better prognostic measures with the potential for mitochondrial-directed therapy.

Our lab has the latest models of the O2k-FluoRespirometer (O2k-Series H), Western blotting, confocal microscopy to study mitochondrial function in both in vitro and in vivo models with a focus on mitochondrial-directed therapies using substrate prodrugs. Relevant in vivo platforms include zebrafish, murine and porcine models of acute critical care illnesses that also combine state of the art physiological monitoring such as PV loop catheters providing realtime physiological data to be linked with cellular function. Our other interests also utilize the use of blood cells as proxy of organ cellular function as a type of biomarker which may provide prognostic function and allow clinicians to better gauge response to therapy.

Combining these elements we aim to better understand the complex interactions of both bioenergetics in issues of acute care to better improve patient care and outcomes.

This work is supported by:
1. R01HL166592 (Jang, PI)
2. R21ES031243 (Jang, PI)
3. R56HL158696 (Jang, PI)

Selected Publications

Janowska JI, Piel S, Saliba N, Kim CD, Jang DH, Karlsson M, Kilbaugh TJ, Ehinger JK: N-methyl carbamate-induced mitochondrial respiratory chain complex I dysfunction ex vivo can be alleviated with a cell-permeable succinate prodrug. Toxicol In Vitro Feb 2020.

Jang DH, Piel S, Greenwood JC, Kelly M, Mazandi VM, Ranganathan A, Lin Y, Starr J, Hallowell T, Shofer FS, Baker WB, Lafontant A, Andersen K, Ehinger J, Kilbaugh TJ, : Alterations in cerebral and cardiac mitochondrial function in a porcine model of acute carbon monoxide poisoning Clinical Toxicology Jan 2021.

Jang DH, Piel S, Greenwood JC, Ehinger JK, Kilbaugh TJ: Emerging Cellular-Based Therapies in Carbon Monoxide Poisoning. Am J Physiol Cell Physiol. June 2021.

Alistair L, Forti RM, Alomaja O, Mesaros C, Piel S, Greenwood JC, Tabul F, Mavroudis CD, Kelly M, Kao S, Shofer FS, Ehinger JK, Kilbaugh TJ, Baker WB, Jang DH: Preliminary Research: Application of non-invasive measure of cytochrome c oxidase redox states and mitochondrial function in a porcine model of carbon monoxide poisoning. Journal of Medical Toxicology April 2022.

Shin S, Chawla S, Jang DH, Mazandi V, Weeks KM, Kilbaugh TJ: Imaging of while matter injury correlates with plasma and tissue biomarkers in pediatric porcine model of traumatic brain injury. J Neurotrauma. Page: 74-85, Jan 2023.

Piel S, Janowska JI, Ward JL, McManus MJ, Jose JS, Starr J, Clayman CL, Jang DH, Karlsson M, Ehinger JK, Kilbaugh TJ. : Succinate prodrugs in combination with atropine and pralidoxime protect cerebral mitochondrial function in a rodent model of acute organophosphate poisoning. Sci Rep. 12(1), Nov 25 2022.

Piel S, Janowska JI, Ward JL, McManus MJ, Aronowitz DI, Janowski PK, Starr J, Hook JN, Hefti MM, Clayman CL, Elmer E, Hansson MJ, Jang DH, Karlsson M, Ehinger JK, Kilbaugh TJ: Succinate prodrugs as treatment for acute metabolic crisis during fluoroacetate intoxication in the rat. Mol Cell Biochem Oct 2022.

Alomaja O, Shofer FS, Greenwood JC, Piel S, Clayman C, Mesaros C, Kao SH, Shin SS, Ehinger JK, Kilbaugh TK, Jang DH: Alteration in Cerebral Metabolism in a Rodent Model of Acute Sub-lethal Cyanide Poisoning. J Med Toxicol Feb 9 2023.

back to top
Last updated: 04/15/2024
The Trustees of the University of Pennsylvania